Congress of Neurological Surgeons selects Wolters Kluwer as its publisher

Wolters Kluwer, Health announced a multi-year agreement reestablishing its collaboration with the Congress of Neurological Surgeons (CNS), the leading organization dedicated to advancing neurosurgery through education and innovation. Beginning in January 2022, Wolters Kluwer will publish three medical specialty journals from CNS’s portfolio including its flagship publication Neurosurgery, one of the most highly cited neurosurgery journals in the world.

2 in 1 Face Mask Against Dust and Virus – Chula Health Innovation in the New Normal

Chula’s Faculty of Engineering joins hands with PTT to develop a 2 in1 face mask, an innovation that protects against PM2.5 dust particles and COVID-19 virus that can be reused more than 15 times, helps reduce waste, is pollution-free, and will be available for sale soon.

Wolters Kluwer equips time-strapped clinicians with evidence-based orthopaedic research summaries from OrthoEvidence

To help clinicians stay current on orthopaedic and musculoskeletal research, Wolters Kluwer, Health announced today that Ovid® users will now have access to OrthoEvidence, a first of its kind evidence-based summary provider for orthopaedic specialists, surgeons, nurses, medical residents and students.

Corporate Employees Learn New Strategies for Helping Youth While Building Workforce of Tomorrow at CFES Brilliant Pathways Training

Corporations concerned with cultivating and recruiting the workforce of tomorrow due to the dramatic effects of COVID-19 on America’s youth are turning to CFES Brilliant Pathways for answers.

Case Western Reserve University biotech startup Rodeo Therapeutics Corp. sold to Amgen Inc.

Rodeo Therapeutics Corp., a drug-development startup founded by two leading researchers from the Case Western Reserve University School of Medicine and a third scientific partner, has been sold to Amgen Inc., a publicly traded international biopharmaceutical company.

Under terms of the agreement, Amgen, based in Thousand Oaks, California, will acquire all outstanding shares of Rodeo for $55 million, plus “future contingent milestone payments potentially worth up to an additional $666 million in cash,” the companies announced today. Total consideration to Rodeo stakeholders could potentially be worth up to $721 million in cash.

RGF® Environmental Group Releases Industry’s First Test Evaluating Aerosolized SARS-CoV-2 Viral Reductions Directly in the Air: PHI-PKG14 PHI-CELL® Proven to Inactivate 99.96% of Airborne SARS-CoV-2 within Simulated Air-Conditioned Space

RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of a third-party test that proves the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater than 99.96% of airborne SARS-CoV-2 virus.

Microsoft features Case Western Reserve’s signature software for anatomy education at two online events

Case Western Reserve University’s HoloAnatomy® Software Suite will star this week in online events that Microsoft is hosting for colleges and universities– Tuesday, Jan. 26, in a webinar titled “A New Vision for Medical Education” and Wednesday, Jan. 27, in Microsoft’s HoloLens Industry Summit, which will include an education break-out session.

GenScript Granted Authorization for cPass™ SARS-CoV-2 Neutralization Antibody Detection Test in Brazil

GenScript USA Inc., the world’s leading research reagent provider, announced today that Brazil’s National Health Surveillance Agency (ANVISA) (Agência Nacional de Vigilância Sanitária) has authorized the use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit for detecting neutralizing antibodies. The cPass test is the first and only ANVISA authorized test for detecting neutralizing antibodies to SARS-CoV-2. Neutralizing antibodies specifically block the ability of a virus to infect a cell and are well-recognized to confer immunity.

Experience “Innovation Uninterrupted” with Sysmex America at AACC 2020

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, will be exhibiting virtually at the 72nd AACC Annual Scientific Meeting & Clinical Lab Expo, December 14 – 17.

AnteoTech enters high sensitivity Assay Development market built on proprietary AnteoBind™ technology.

AnteoTech marks its entry into the Assay Development market through the design of a high sensitivity COVID-19 Antigen Rapid Test. The test uses an AnteoBind™ activated Europium particle to enable the detection of low viral loads. AnteoTech is pleased to announce the expansion of its business to include Assay Development in addition to its existing Raw Material Supply business.

AACC Announces 2020 Corporate Supporter Award Winners; Thanks Organizations for Their Invaluable Support

AACC is pleased to announce the recipients of the AACC 2020 Top Corporate Supporter Awards. This year, AACC recognizes 45 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.

New Worthington Enzyme and Biochemical Product Catalog Features Solutions for Life Science Research and Bulk Requirements

Worthington, the leading supplier of specialty enzymes for over 70 years, announces today the publication of an expanded, 2021-22 Enzyme and Biochemical Product Catalog. As a primary enzyme producer for biochemistry, cell biology, molecular biology, pre-clinical research and bioprocessing applications, Worthington is the “go-to” expert in enzyme technology.

ALCEDIAG to announce game changing solutions in mental health diseases & diagnostic tools based on RNA-editing blood biomarkers

ALCEDIAG, one of 3 finalists for the “Disruptive Technology Award” at the annual AACC meeting 2020, will be holding a press conference to announce a game-changing technology and diagnostic tool for precision medicine in psychiatry: EDIT-BTM, the very first blood test for a high-performance differential diagnosis of unipolar depression and bipolar disorder.

Media Advisory: AnteoTech enters high sensitivity Assay Development market built on proprietary AnteoBind™ technology.

AnteoTech marks its entry into the Assay Development market through the design of a high sensitivity COVID-19 Antigen Rapid Test. The test uses an AnteoBind™ activated Europium particle to enable the detection of low viral loads. AnteoTech is pleased to announce the expansion of its business to include Assay Development in addition to its existing Raw Material Supply business.

Baebies Selected as Finalist for the 2020 AACC Disruptive Technology Award

Baebies has been named a finalist for the 2020 American Association for Clinical Chemistry’s (AACC) Disruptive Technology Award for FINDER®, a near-patient testing platform. As a growth-stage company developing diagnostic products to provide a healthy start for children everywhere, Baebies FINDER tests for diseases from low blood volume (50 µL) with a turn-around time of approximately 15 minutes after sample introduction.

Seattle Cancer Care Alliance Selected as an Authorized Treatment Center for TecartusTM, a Novel Immunotherapy Treatment

Seattle Cancer Care Alliance (SCCA), the only National Comprehensive Cancer Network (NCCN)-designated cancer center in Washington state, has been selected as an authorized treatment center to offer brexucabtagene autoleucel, also known by the brand name TecartusTM. It is the first and only chimeric antigen receptor (CAR) T-cell therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL).

Globus Moves 1 Exabyte

Globus, a leading research data management service, reached a huge milestone by breaking the exabyte barrier. While it took over 2,000 days for the service to transfer the first 200 petabytes (PB) of data, the last 200PB were moved in just 247 days. This rapidly accelerating growth is reflected by the more than 150,000 registered users who have now transferred over 120 billion files using Globus.

Award-winning Austrian supplement containing “spermidine” is now available to consumers in the US

DENVER, Sept. 9, 2020 /PRNewswire/ — TLL The Longevity Labs GmbH, an Austrian-based life sciences company, and its wholly-owned, US subsidiary, Longevity Labs Inc., announce the market-launch of sales in the US of its award-winning dietary supplement, spermidineLIFE®. spermidineLIFE® is the world’s first naturally extracted and clinically tested dietary supplement to promote cellular renewal. The active ingredient, spermidine, is considered key to slowing down the cellular aging process.

Shaping the Future of Food

The Donald Danforth Plant Science Center announced the lineup of TableTalks, a series of conversations shaping the future of food that will follow each AgTech NEXT conference session on Tuesdays, September 22 – November 10 from 1:30 – 2:15 PM.

ANSWERING THE COVID-19 CALL TO ACTION: SavantX Dataset Search and Analysis Technology Offered at No-Cost to Researchers, Scientists, and Medical Professionals

In response to the COVID-19 global pandemic, SavantX has deployed a no-cost AI-enabled web application to help medical and research professionals rapidly search, analyze and visualize the CORD-19 dataset to gain deep insight into hidden relationships within the data and answer important questions with no data science experience necessary.